Phase II trial of bimonthly leucovorin, 5-fluorouracil and gemcitabine for advanced pancreatic adenocarcinoma (FOLFUGEM)
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/12/5/675/19479265/12-5-675.pdf
Reference24 articles.
1. National cancer prevalence estimation in France;Colonna;Int J Cancer,2000
2. Cancer of the pancreas;Evans,1997
3. Cancer of the pancreas 50 years of surgery;Gudjonsson;Cancer,1987
4. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: A randomized trial;Burris;J Clin Oncol,1997
5. Chemotherapy improves survival and quality of life in advanced pancreatic biliary cancer;Glimeluis;Ann Oncol,1996
Cited by 43 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A Phase II Trial of Flouro-Gem as a First Line Treatment of Metastatic Adenocarcinoma of the Pancreas (GEFLUPAN trial);2024-01-08
2. Changing paradigm of radiation therapy for the treatment of pancreatic cancer;Precision Radiation Oncology;2019-12
3. Evaluation of Phase II Trial Design in Advanced Pancreatic Cancer;Pancreas;2019-11
4. A Pilot Trial of Molecularly Tailored Therapy for Patients with Metastatic Pancreatic Ductal Adenocarcinoma;Journal of Pancreatic Cancer;2019-05
5. The Role of Log Odds of Positive Lymph Nodes in Predicting the Survival after Resection for Ampullary Adenocarcinoma;Pathology & Oncology Research;2019-01-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3